Bukwang Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	114,423	96,208	90,091	151,227	85,517	82,777
Short-Term Investments	95,000	120,000	40,000	-	-	1,500
Cash & Short-Term Investments	209,423	216,208	130,091	151,227	85,517	84,277
Cash Growth	57.68%	66.20%	-13.98%	76.84%	1.47%	-5.93%
Accounts Receivable	26,813	27,845	23,559	35,729	87,950	90,428
Other Receivables	2,508	1,835	994.31	1,647	360.04	2,413
Receivables	31,321	29,681	24,553	37,376	88,310	92,842
Inventory	54,593	52,205	41,667	56,832	38,607	39,294
Prepaid Expenses	295.08	223.5	398.29	166.97	173.46	205.7
Other Current Assets	4,056	4,860	7,030	8,576	6,134	3,476
Total Current Assets	299,689	303,177	203,739	254,179	218,741	220,095
Property, Plant & Equipment	145,671	144,985	141,481	122,789	123,960	124,531
Long-Term Investments	14,917	15,683	16,775	31,626	35,132	36,963
Goodwill	-	-	406.62	878.73	834.51	828.7
Other Intangible Assets	4,887	5,052	5,868	9,177	6,157	6,151
Long-Term Deferred Tax Assets	-	-	-	-	-	3.63
Other Long-Term Assets	4,435	7,397	4,910	10,368	16,105	8,843
Total Assets	469,599	476,295	373,180	429,017	400,929	397,417
Accounts Payable	8,987	7,297	5,062	2,368	16,530	7,421
Accrued Expenses	-	2,579	1,907	2,978	1,755	1,776
Current Portion of Long-Term Debt	79,677	79,532	-	-	-	-
Current Portion of Leases	442.04	295.3	130.19	217.6	242.91	444.17
Current Income Taxes Payable	-	-	-	357.47	4,312	3,996
Other Current Liabilities	28,533	28,115	28,299	91,622	21,764	23,358
Total Current Liabilities	117,639	117,818	35,398	97,544	44,603	36,995
Long-Term Debt	-	-	79,024	78,525	-	-
Long-Term Leases	535.45	513.55	269.91	644.17	687.88	1,114
Long-Term Deferred Tax Liabilities	17,230	16,615	13,917	10,068	11,011	11,217
Other Long-Term Liabilities	416.55	416.55	425.12	7,971	72,780	68,030
Total Liabilities	135,821	135,363	129,035	194,752	129,082	117,356
Common Stock	51,507	51,507	36,402	36,402	36,402	36,402
Additional Paid-In Capital	85,518	85,518	12,452	4,808	6,800	7,357
Retained Earnings	167,109	173,433	166,822	225,783	258,585	264,703
Treasury Stock	-	-	-	-50,784	-50,784	-50,784
Comprehensive Income & Other	29,365	30,142	28,000	10,103	12,215	11,930
Total Common Equity	333,498	340,600	243,676	226,311	263,217	269,608
Minority Interest	280.2	332.14	469.85	7,953	8,630	10,453
Shareholders' Equity	333,779	340,932	244,146	234,265	271,847	280,061
Total Liabilities & Equity	469,599	476,295	373,180	429,017	400,929	397,417
Total Debt	80,654	80,341	79,424	79,387	930.79	1,558
Net Cash (Debt)	128,769	135,867	50,667	71,840	84,586	82,719
Net Cash Growth	144.55%	168.16%	-29.47%	-15.07%	2.26%	21.57%
Net Cash Per Share	1493.28	1644.73	748.11	1049.46	1235.65	1208.27
Filing Date Shares Outstanding	49.06	98.66	68.45	68.45	68.45	68.45
Total Common Shares Outstanding	49.06	98.66	68.45	68.45	68.45	68.45
Working Capital	182,050	185,360	168,341	156,634	174,138	183,101
Book Value Per Share	6797.74	3452.10	3559.67	3306.00	3845.13	3938.48
Tangible Book Value	328,611	335,548	237,401	216,255	256,226	262,628
Tangible Book Value Per Share	6698.13	3400.89	3468.00	3159.10	3743.01	3836.52
Land	112,939	112,939	113,314	92,875	92,875	92,875
Buildings	52,282	52,274	51,499	51,450	50,602	50,602
Machinery	49,594	47,785	49,276	48,406	48,080	46,343
Construction In Progress	366.03	527.8	311.17	-	76.21	-